why choose us

First received: December 22, 2024

Clinical Trial: Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hand, Foot, and Mouth Disease (HFMD)

Study Type: INTERVENTIONAL


Official Title: Randomized, Double-blind, Controlled Phase I/II Clinical Trial on the Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell) in Healthy Adults and Chi

Brief Summary: The trial aims to assess the tolerability, safety, and immunogenicity of the tetravalent inactivated enterovirus vaccine in adults and children aged 6 months to 12 years.The main questions it aims to answer are:Phase ?: The safety of the investigational vaccine in the target population based on adverse events (AEs);Phase ?: The immunogenicity of the investigational vaccine in the target population.In Phase I, researchers will compare the safety of the investigational vaccine at low, medium, and high doses with the…

Read more